<DOC>
	<DOC>NCT01344733</DOC>
	<brief_summary>The study will only detect hypomanic symptoms in treatment resistant MDD patients by mean of HCL-32 administration. Further re-evaluation of MDD diagnosis is not a direct aim of the study. No efficacy and tolerability of pharmacological treatments will be assessed. Patients matching inclusion and exclusion criteria will be enrolled consecutively; each investigator will include the first 10 to 40 patients that will be visited as treatment resistant MDD.</brief_summary>
	<brief_title>A Non Interventional Study to Investigating the Ratio of Mis-diagnosed Bipolar Symptoms in Patient With Major Depressive Disorder (MDD)</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<criteria>Written informed consent form Male and Female age: 1865 years Diagnosis of MDD according to DSMIV TR (296.3 x Major Depressive Disorder, recurrent) Treatment resistance defined as nonresponse to at least 2 antidepressants given in an ade Patients already participating in clinical trial or any other interventional study Patients unable to understand HCL32 item meaning</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>MDD</keyword>
</DOC>